1. Aldosterone and CKD in metabolic syndrome

   • Toshiro Fujita

   Invited Commentary 23 November 2008 Pages: 421 - 423

2. Treating hypertension prevents heart failure

   • M. Gary Nicholls

   Invited Commentary 23 November 2008 Pages: 424 - 425

3. Endothelin antagonist for the treatment of resistant hypertension

   • Steven A. Atlas

   Clinical Trials Report 23 November 2008 Pages: 429 - 431

4. Aliskiren combined with losartan: Thor’s hammer or Sigurd’s sword?

   • Thomas R. Lux
   • Heinrich Taegtmeyer

   Clinical Trials Report 23 November 2008 Pages: 432 - 433

5. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease

   • Jarrod D. Knudson
   • Gregory A. Payne
   • Johnathan D. Tune

   OriginalPaper 23 November 2008 Pages: 434 - 439

6. Mediators of sympathetic activation in metabolic syndrome obesity

   • Nora E. Straznicky
   • Nina Eikelis
   • Murray D. Esler

   OriginalPaper 23 November 2008 Pages: 440 - 447

7. Impaired cardiac function in leptin-deficient mice

   • Jun Ren
   • Heng Ma

   OriginalPaper 23 November 2008 Pages: 448 - 453

8. Cardiomyocyte apoptosis in animal models of obesity

   • Premal S. Trivedi
   • Lili A. Barouch

   OriginalPaper 23 November 2008 Pages: 454 - 460

9. The PAT family of lipid droplet proteins in heart and vascular cells

   • Antoni Paul
   • Lawrence Chan
   • Perry E. Bickel

   OriginalPaper 23 November 2008 Pages: 461 - 466

10. Effect of angiotensin II type 1 receptor blockers in patients with self-monitored morning hypertension

    • George Mansour
    • Janette Mansour

    Clinical Trials Report 23 November 2008 Pages: 469 - 470

11. Renal protective effect of renin inhibition

    • Theodore A. Kotchen

    Clinical Trials Report 23 November 2008 Pages: 471 - 472

12. Vaccination: A novel strategy for inhibiting the renin-angiotensin-aldosterone system

    • Alan H. Gradman
    • Rehka Pinto

    OriginalPaper 23 November 2008 Pages: 473 - 479

13. Perioperative control of hypertension: When will it adversely affect perioperative outcome?

    • John W. Sear

    OriginalPaper 23 November 2008 Pages: 480 - 487

14. Genetic determinants of hypertension: An update

    • Michael Harrison
    • Karen Maresso
    • Ulrich Broeckel

    OriginalPaper 23 November 2008 Pages: 488 - 495

15. Resistant hypertension and hyperaldosteronism

    • Carolina C. Gonzaga
    • David A. Calhoun

    OriginalPaper 23 November 2008 Pages: 496 - 503